Title | Thalamic deep brain stimulation in traumatic brain injury: a phase 1, randomized feasibility study. |
Publication Type | Journal Article |
Year of Publication | 2023 |
Authors | Schiff ND, Giacino JT, Butson CR, Choi EYoung, Baker JL, O'Sullivan KP, Janson AP, Bergin M, Bronte-Stewart HM, Chua J, DeGeorge L, Dikmen S, Fogarty A, Gerber LM, Krel M, Maldonado J, Radovan M, Shah SA, Su J, Temkin N, Tourdias T, Victor JD, Waters A, Kolakowsky-Hayner SA, Fins JJ, Machado AG, Rutt BK, Henderson JM |
Journal | Nat Med |
Volume | 29 |
Issue | 12 |
Pagination | 3162-3174 |
Date Published | 2023 Dec |
ISSN | 1546-170X |
Keywords | Brain Injuries, Traumatic, Deep Brain Stimulation, Feasibility Studies, Humans, Quality of Life, Thalamus |
Abstract | Converging evidence indicates that impairments in executive function and information-processing speed limit quality of life and social reentry after moderate-to-severe traumatic brain injury (msTBI). These deficits reflect dysfunction of frontostriatal networks for which the central lateral (CL) nucleus of the thalamus is a critical node. The primary objective of this feasibility study was to test the safety and efficacy of deep brain stimulation within the CL and the associated medial dorsal tegmental (CL/DTTm) tract.Six participants with msTBI, who were between 3 and 18 years post-injury, underwent surgery with electrode placement guided by imaging and subject-specific biophysical modeling to predict activation of the CL/DTTm tract. The primary efficacy measure was improvement in executive control indexed by processing speed on part B of the trail-making test.All six participants were safely implanted. Five participants completed the study and one was withdrawn for protocol non-compliance. Processing speed on part B of the trail-making test improved 15% to 52% from baseline, exceeding the 10% benchmark for improvement in all five cases.CL/DTTm deep brain stimulation can be safely applied and may improve executive control in patients with msTBI who are in the chronic phase of recovery.ClinicalTrials.gov identifier: NCT02881151 . |
DOI | 10.1038/s41591-023-02638-4 |
Alternate Journal | Nat Med |
PubMed ID | 38049620 |
PubMed Central ID | 8126422 |
Grant List | R01 NS111019 / NS / NINDS NIH HHS / United States UH3 NS095554 / NS / NINDS NIH HHS / United States |
Related Institute:
Brain Health Imaging Institute (BHII)